Abiopharma

🔍 Keirn Cris (Executive)

Company: Turtle Beach Corp (TBCH)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 4,266 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 80,829.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,173 shares of Common Stock at $11.22 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 78,656.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 12,928 shares of Performance Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,928.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
• Sold 4,266 shares of Performance Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,662.00 | transaction_form_type: 4 | Footnotes: F3, F5, F5
• Holds 7,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 7,000.00 | Footnotes: F6, F7, F7
• Holds 13,104 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 13,104.00 | Footnotes: F6, F8, F8
• Holds 25,632 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 25,632.00 | Footnotes: F6, F9, F9
• Holds 61,154 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 61,154.00 | Footnotes: F6, F10, F10
• Holds 19,167 shares of Stock Option (Right to Buy) at $12.1 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2029-04-01 | shares_owned_after: 19,167.00 | Footnotes: F11
• Holds 12,605 shares of Stock Option (Right to Buy) at $5.95 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2030-04-01 | shares_owned_after: 12,605.00 | Footnotes: F11

Footnotes:

• F1: Performance stock units ("PSUs") were converted into common stock on a one-for-one basis.
• F2: Represents shares withheld to satisfy tax withholding obligations upon the vesting of PSUs awarded to the reporting person.
• F3: These securities are PSUs representing a contingent right to receive one share of Turtle Beach Corporation common stock or, cash with a value equal to the fair market value of the underlying common stock or, a combination thereof.
• F4: Acquired upon achievement of certain performance criteria of PSUs granted to the reporting person on April 1, 2025 under the Turtle Beach Corporation 2023 Stock Based Incentive Compensation Plan, as amended. Performance was measured over 12 months (May 1, 2025 through May 1, 2026) with respect to a stock price performance metric and 12 months (January 1, 2025 through December 31, 2025) with respect to an Adjusted EBITDA performance metric, with additional time-based vesting for earned units over two years.
• F5: These PSUs granted on April 1, 2025 vest as follows: 4,266 on May 1, 2026, 4,266 on April 1, 2027 and 4,396 on April 1, 2028.
• F6: The securities are restricted stock units ("RSUs") representing a contingent right to receive one share of Turtle Beach Corporation common stock or, cash with a value equal to the fair market value of the underlying common stock or, a combination thereof.
• F7: These RSUs vest in equal annual installments until April 1, 2027.
• F8: These RSUs vest in equal annual installments until April 1, 2028.
• F9: These RSUs vest in equal annual installments until April 1, 2029.
• F10: One-quarter of these RSUs will vest on April 1, 2027, with the remainder of the RSUs vesting in equal annual installments until April 1, 2030.
• F11: These options were exercisable as of the transaction date.